top of page

Publications

Casein kinase 1 delta (CK1delta) interacts with the SNARE associated protein snapin

The role of the casein kinase 1 (CK1) family in different signaling pathways linked to cancer development

Astrocytes, the rising stars of the glioblastoma microenvironment

Shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma

LMTK3 confers chemo-resistance in breast cancer

Tumor-Stromal Cell Communication: Small Vesicles Signal Big Changes

Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma

Direct Effects of Anti-Angiogenic Therapies on Tumor Cells: VEGF Signaling

Strategies in functional proteomics: Unveiling the pathways to precision oncology

Extracellular vesicles swarm the cancer microenvironment: from tumor-stroma communication to drug intervention

Proteome-wide dataset supporting functional study of tyrosine kinases in breast cancer

ATG9A loss confers resistance to trastuzumab via c-Cbl mediated Her2 degradation

LMTK3 escapes tumour suppressor miRNAs via sequestration of DDX5

Targeting tumor-stroma crosstalk: the example of the NT157 inhibitor

The many-faced KSR1: a tumor suppressor in breast cancer

Reply: When does a human being die?

LMTK3 Represses Tumor Suppressor-like Genes through Chromatin Remodeling in Breast Cancer

Characterization of the Tyrosine Kinase-Regulated Proteome in Breast Cancer by Combined use of RNA interference (RNAi) and Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) Quantitative Proteomics

Proteomic profile of KSR1-regulated signalling in response to genotoxic agents in breast cancer

When does a human being die?

Broader implications of SILAC-based proteomics for dissecting signaling dynamics in cancer

Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancer

Targeting lemurs against cancer metastasis

The kinase LMTK3 promotes invasion in breast cancer through GRB2-mediated induction of integrin β₁

KSR1 regulates BRCA1 degradation and inhibits breast cancer growth

MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma

SILAC-based phosphoproteomics reveals an inhibitory role of KSR1 in p53 transcriptional activity via modulation of DBC1

Prognostic role of lemur tyrosine kinase-3 germline polymorphisms in adjuvant gastric cancer in Japan and the United States

The dual function of KSR1: a pseudokinase and beyond

Cancer stem cells--therapeutic targeting or therapy?

The regulatory roles of phosphatases in cancer

Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen

Claudin-1 as a promoter of EMT in hepatocellular carcinoma

LATS2 is a modulator of estrogen receptor alpha

Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo

LMTK3 is implicated in endocrine resistance via multiple signaling pathways

MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors

The role of pseudokinases in cancer

Lemur tyrosine kinase-3 (LMTK3) in cancer and evolution

LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome

Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer

The potential role of cyclooxygenase-2 (COX-2) during early breast cancer therapy

Kinases as targets in the treatment of solid tumors

The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response

CK1delta modulates the transcriptional activity of ERalpha via AIB1 in an estrogen-dependent manner and regulates ERalpha-AIB1 interactions

The phosphorylated membrane estrogen receptor and cytoplasmic signaling and apoptosis proteins in human breast cancer

Bendamustine as a model for the activity of alkylating agents

Anti-apoptotic and growth-stimulatory functions of CK1 delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivo

Phosphorylation at Ser244 by CK1 determines nuclear localization and substrate targeting of PKD2

Clinical significance of circulating tumor cells

Protein kinases as targets for cancer treatment

Phosphorylation of CK1delta: identification of Ser370 as the major phosphorylation site targeted by PKA in vitro and in vivo

Targeting LMTK3 in ovarian cancer: A dual role in prognosis and therapy

A brain metastasis liquid biopsy: Where are we now?

The brain-specific kinase LMTK3 regulates neuronal excitability by decreasing KCC2-dependent neuronal Cl(-) extrusion

Management of glioblastoma in elderly patients: A review of the literature

MISEV2023: Shaping the Future of EV Research by Enhancing Rigour, Reproducibility and Transparency

Kinome-Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma

Decoding the Tumour Microenvironment: Molecular Players, Pathways, and Therapeutic Targets in Cancer Treatment

Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

A revised nomenclature for the lemur family of protein kinases

A prognostic model of drug tolerant persister-related genes in lung adenocarcinoma based on single cell and bulk RNA sequencing data

Shooting the messenger: a systematic review investigating extracellular vesicle isolation and characterisation methods and their influence on understanding extracellular vesicles-radiotherapy interactions in glioblastoma

The role of non-coding RNAs in extracellular vesicles in breast cancer and their diagnostic implications

Estrogen receptor status heterogeneity in breast cancer tumor: role in response to endocrine treatment

Propranolol reduces IFN-γ driven PD-L1 immunosuppression and improves anti-tumour immunity in ovarian cancer

The Inhibitory Properties of a Novel, Selective LMTK3 Kinase Inhibitor

Design and reporting of phase III oncology trials with prospective biomarker validation

Incorporating Immunotherapy in the Management of Gastric Cancer: Molecular and Clinical Implications

Effectiveness of X-ray micro-CT applications upon mafic and ultramafic ophiolitic rocks

PDGF-R inhibition induces glioblastoma cell differentiation via DUSP1/p38(MAPK) signalling

Alternative splicing events in tumor immune infiltration in renal clear cell carcinomas

Extracellular Vesicles as Mediators of Therapy Resistance in the Breast Cancer Microenvironment

Definition of an Inflammatory Biomarker Signature in Plasma-Derived Extracellular Vesicles of Glioblastoma Patients

A Prediction Model Using Alternative Splicing Events and the Immune Microenvironment Signature in Lung Adenocarcinoma

Tuneable synthetic reduced graphene oxide scaffolds elicit high levels of three-dimensional glioblastoma interconnectivity in vitro

Diving into the dark kinome: lessons learned from LMTK3

Reconstituting Immune Surveillance in Breast Cancer: Molecular Pathophysiology and Current Immunotherapy Strategies

A Pan-Cancer Analysis of SMARCA4 Alterations in Human Cancers

The role of astrocytes in brain metastasis at the interface of circulating tumour cells and the blood brain barrier

The multifaceted role of lemur tyrosine kinase 3 in health and disease

Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer

Phosphorylation and Stabilization of PIN1 by JNK Promote Intrahepatic Cholangiocarcinoma Growth

Cancer gene therapy 2020: highlights from a challenging year

Correction to: KSR1 regulates BRCA1 degradation and inhibits breast cancer growth

Correction to: LMTK3 inhibition affects microtubule Stability

LMTK3 inhibition affects microtubule stability

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)(1)

Graphene-Induced Transdifferentiation of Cancer Stem Cells as a Therapeutic Strategy against Glioblastoma

The structure-function relationship of oncogenic LMTK3

Androgen receptor signaling regulates the transcriptome of prostate cancer cells by modulating global alternative splicing

Langmuir Films of Layered Nanomaterials: Edge Interactions and Cell Culture Applications

Breaking through the glioblastoma micro-environment via extracellular vesicles

Three Method-Combination Protocol for Improving Purity of Extracellular Vesicles

PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progression

Cancer Gene Therapy: vision and strategy for the new decade

Evaluation of Spheroid 3D Culture Methods to Study a Pancreatic Neuroendocrine Neoplasm Cell Line

Cell-derived extracellular vesicles can be used as a biomarker reservoir for glioblastoma tumor subtyping

Endocrine Resistance in Hormone Receptor Positive Breast Cancer-From Mechanism to Therapy

EGF and IGF1 affect sunitinib activity in BP-NEN: new putative targets beyond VEGFR?

Screenshot 2025-04-17 at 11.26.19.png
bottom of page